Home > Items where Subject is "J Health care, prevention, harm reduction and treatment > Risk and needs assessment > Risk assessment"

up arrow imageUp a level
Export as
Group by: Item Type | No Grouping
Number of items at this level: 160.

Article

Oliver, Dominic and Englund, Amir and Chesney, Edward and Chester, Lucy and Wilson, Jack and Sovi, Simina and Wigroth, Stina and Hodsoll, John and Strang, John and Murray, Robin M and Freeman, Tom P and Fusar-Poli, Paolo and McGuire, Philip (2024) Cannabidiol does not attenuate acute delta-9-tetrahydrocannabinol-induced attentional bias in healthy volunteers: a randomised, double-blind, cross-over study. Addiction , 119 , (2) , pp. 322-333.

Mestre-Bach, Gemma and Potenza, Marc N (2023) Potential biological markers and treatment implications for binge eating disorder and behavioral addictions. Nutrients , 15 , (4) .

Robert, Marion and Jouanjus, Emilie and Khouri, Charles and Fouilhé Sam-Laï, Nathalie and Revol, Bruno (2023) The opioid epidemic: a worldwide exploratory study using the WHO pharmacovigilance database. Addiction , 118 , (4) , pp. 771-775.

Andrews, Rachael and Jorge, Rita and Christie, Rachel and Gallegos, Ana (2023) From JWH-018 to OXIZIDS: structural evolution of synthetic cannabinoids in the European Union from 2008 to present day. Drug Testing and Analysis , 15 , (4) , pp. 378-387. (In Press)

Griffin, Eve and Corcoran, Paul and Arensman, Ella and Kavalivdou, K and Perry, Ivan J and McMahon, Elaine M (2023) Suicide risk following hospital attendance with self-harm: a national cohort study in Ireland. Nature Mental Health , 1 , pp. 982-989.

Vu, Thi Hoang and Bishop, Jared and McGill, Leigh and Valmadrid, Luke and Golden, Shelley and Emmerling, Dane and Saeugling, Seth (2022) Using systems-mapping to address Adverse Childhood Experiences (ACEs) and trauma: a qualitative study of stakeholder experiences. PLoS ONE , 17 , (8) .

Vozoris, Nicholas T and Zhu, Jingqin and Ryan, Clodagh M and Chow, Chung-Wai and To, Teresa (2022) Cannabis use and risks of respiratory and all-cause morbidity and mortality: a population-based, data-linkage, cohort study. BMJ Open Respiratory Research , 9 .

Dasgupta, Nabarun and Figgatt, Mary C (2022) Invited commentary: Drug checking for novel insights into the unregulated drug supply. American Journal of Epidemiology , 191 , (2) , pp. 248-252.

Exner-Cortens, Deinera and Baker, Elizabeth and Gray, Shawna and Fernandez Conde, Cristina and Rivera, Rocio Ramirez and Van Bavel, Marisa and Vezina, Elisabeth and Ambrose, Aleta and Pawluk, Chris and Schwartz, Kelly D and Arnold, Paul D (2021) School-based suicide risk assessment using ehealth for youth: systematic scoping review. JMIR Mental Health , 8 , (9) , e29454.

McKay, Michael T and Perry, John L and Cole, Jon C and Percy, Andrew and Sumnall, Harry R (2021) One rule for one, and a different rule for another: The case of the Parental Rules about Alcohol Questionnaire. Drug and Alcohol Dependence , 225 , p. 108824.

Au, Vivian Y O and Rosic, Tea and Sanger, Nitika and Hillmer, Alannah and Chawar, Caroul and Worster, Andrew and Marsh, David C and Thabane, Lehana and Samaan, Zainab (2021) Factors associated with opioid overdose during medication-assisted treatment: How can we identify individuals at risk? Harm Reduction Journal , 18 , (71) .

Gunn, Christine M and Maschke, Ariel and Harris, Miriam and Schoenberger, Samantha F and Sampath, Spoorthi and Walley, Alexander Y and Bagley, Sarah M (2021) Age-based preferences for risk communication in the fentanyl era: 'A lot of people keep seeing other people die and that's not enough for them'. Addiction , 116 , (6) , pp. 1495-1504.

Büchele, Natascha and Keller, Lucas and Zeller, Anja C and Schrietter, Freya and Treiber, Julia and Gollwitzer, Peter M and Odenwald, Michael (2020) The effects of pre-intervention mindset induction on a brief intervention to increase risk perception and reduce alcohol use among university students: a pilot randomized controlled trial. PLoS ONE , 15 , (9) , e0238833.

Palumbo, Sarah A and Adamson, Kayleigh M and Krishnamurthy, Sarathbabu and Manoharan, Shivani and Beiler, Donielle and Seiwell, Anthony and Young, Colt and Metpally, Raghu and Crist, Richard C and Doyle, Glenn A and Ferraro, Thomas N and Li, Mingyao and Berrettini, Wade H and Robishaw, Janet D and Troiani, Vanessa (2020) Assessment of probable opioid use disorder using electronic health record documentation. JAMA Network Open , 3 , (9) , e2015909.

Maneiro, Lorena and Navas, María Patricia and Van Geel, Mitch and Cutrín, Olalla and Vedder, Paul (2020) Dark Triad Traits and risky behaviours: identifying risk profiles from a person-centred approach. International Journal of Environmental Research and Public Health , 17 , (17) .

Leos-Toro, Cesar and Fong, Geoffrey T and Meyer, Samantha B and Hammond, David (2020) Cannabis health knowledge and risk perceptions among Canadian youth and young adults. Harm Reduction Journal , 17 , (54) , p. 54.

Soneson, Emma and Howarth, Emma and Ford, Tamsin and Humphrey, Ayla and Jones, Peter B and Thompson Coon, Jo and Rogers, Morwenna and Anderson, Joanna K (2020) Feasibility of school-based identification of children and adolescents experiencing, or at-risk of developing, mental health difficulties: a systematic review. Prevention Science , 21 , (5) , pp. 581-603.

Artigiani, Eleanor Erin and Wish, Eric D (2020) Introducing the National Drug Early Warning System. Current Opinion in Psychiatry , 33 , (4) , pp. 319-325.

Costa, Marie and Barré, Tangui and Coste, Marion and Yaya, Issifou and Berenger, Cyril and Tanti, Marc and Cutarella, Christophe and Mora, Marion and Poloméni, Pierre and Maynard, Marianne and Teuma, Danielle and Bazin, Michaël and Maradan, Gwenaelle and Roux, Perrine and Carrieri, Patrizia Maria (2020) Screening and care for alcohol use disorder in France: expectations, barriers and levers using a mixed-methods approach. BMC Public Health , 20 , (358) , p. 358.

Maghsoudi, N and McDonald, K and Stefan, C and Beriault, D R and Mason, K and Barnaby, L and Altenberg, J and MacDonald, R D and Caldwell, J and Nisenbaum, R and Leece, P and Watson, T M and Tupper, K W and Kufner, L and Scheim, A I and Werb, D (2020) Evaluating networked drug checking services in Toronto, Ontario: study protocol and rationale. Harm Reduction Journal , 17 .

Seo, Sambu and Beck, Anne and Matthis, Caroline and Genauck, Alexander and Banaschewski, Tobias and Bokde, Arun L W and Bromberg, Uli and Büchel, Christian and Quinlan, Erin Burke and Flor, Herta and Frouin, Vincent and Garavan, Hugh and Gowland, Penny and Ittermann, Bernd and Martinot, Jean-Luc and Paillère Martinot, Marie-Laure and Nees, Frauke and Papadopoulos Orfanos, Dimitri and Poustka, Luise and Hohmann, Sarah and Fröhner, Juliane H and Smolka, Michael N and Walter, Henrik and Whelan, Robert and Desrivières, Sylvane and Heinz, Andreas and Schumann, Gunter and Obermayer, Klaus (2019) Risk profiles for heavy drinking in adolescence: differential effects of gender. Addiction Biology , 24 , (4) , pp. 787-801.

Clair, Carole and Mueller, Yolanda and Livingstone‐Banks, Jonathan and Burnand, Bernard and Camain, Jean Yves and Cornuz, Jacques and Rège Walther, Myriam and Selby, Kevin and Bize, Raphaël (2019) Biomedical risk assessment as an aid for smoking cessation. Cochrane Database of Systematic Reviews , (3) .

Drug and Alcohol Findings. (2018) Preventing alcohol and tobacco exposed pregnancies: CHOICES Plus in primary care. Drug and Alcohol Findings Research Analysis .

Drug and Alcohol Findings. (2017) Intervention targets personality traits of high-risk London pupils. Drug and Alcohol Findings Review Analysis , (5 May 2017) .

O'Halloran, Laura and Nymberg, Charlotte and Jollans, Lee and Garavan, Hugh and Whelan, Robert (2017) The potential of neuroimaging for identifying predictors of adolescent alcohol use initiation and misuse. Addiction , 112 , (4) , pp. 719-726.

Haydon, Helen M and Obst, Patricia L and Lewis, Ioni (2016) Beliefs underlying women’s intentions to consume alcohol. BMC Women's Health , 16 , (36) .

Levy, Sharon JL and Williams, Janet F (2016) Substance use screening, brief intervention, and referral to treatment. Pediatrics , 138 , (1) .

Mitchell, Simon and Gao, Jennifer and Hallett, Mark and Voon, Valarie (2016) The role of social novelty in risk seeking and exploratory behavior: implications for addictions. PLoS ONE , 11 , (7) .

O'Gorman, Aileen (2016) Chillin, buzzin, getting mangled, and coming down: Doing differentiated normalisation in risk environments. Drugs: Education Prevention and Policy , 23 , (3) , pp. 247-254.

Simpson, Alan and Hannigan, Ben and Coffey, Michael and Barlow, Sally and Cohen, Rachel and Jones, Aled and Všetečková, Jitka and Faulkner, Alison and Thornton, Alexandra and Cartwright, Martin (2016) Recovery-focused care planning and coordination in England and Wales: a cross-national mixed methods comparative case study. BMC Psychiatry , 16 , (1) , p. 147.

Horan, John Aidan and Deasy, Conor and Henry, Kieran and O'Brien, Declan and Van Hout, Marie Claire (2015) Overdose risk perceptions and experience of overdose among heroin users in Cork, Ireland. Preliminary results from a pilot overdose prevention study. Heroin Addiction and Related Clinical Problems , 17 , (5) , pp. 19-26.

Lyons, Suzi (2015) Urban overdose hotspots in Dublin. Drugnet Ireland , Issue 53, Spring 2015 , pp. 11-12.

Lynn, Ena (2014) The overdose risk information (ORION) project. Drugnet Ireland , Issue 48, Winter 2013 , p. 14.

Hohman, Melinda and Loughran, Hilda (2013) What do female clients want from residential treatment? The relationship between expressed and assessed needs, psychosocial characteristics, and program outcome. Journal of Dual Diagnosis , 9 , (1) .

Arkins, Brigid and Tyrell, Mark and Herlihy, Eddie and Crowley, Brenda and Lynch, Rose (2013) Assessing the reasons for deliberate self-harm in young people. Mental Health Practice , 16 , (7) , pp. 28-32.

(2012) Effectiveness Bank Bulletin (Heart screening in methadone maintenance treatment). Effectiveness Bank Bulletin , 18 Jul .

Casey, Martina and Adamson, Gary and Shevlin, Mark and McKinney, Adele (2012) The role of craving in AUDs: dimensionality and differential functioning in the DSM-5. Drug and Alcohol Dependence , 125 , (1-2) , pp. 75-80.

Long, Jean and Keane, Martin (2011) NACD study on risk and protective factors for substance use among young people. Drugnet Ireland , Issue 36, Winter 2010 , pp. 16-18.

Keane, Martin (2011) Commentary on NACD study on risk and protective factors for substance use. Drugnet Ireland , Issue 36, Winter 2010 , p. 19.

Duggan, Michelle and Kavanagh, Brian P (2010) Perioperative modifications of respiratory function. Best Practice & Research: Clinical Anaesthesiology , 24 , (2) , pp. 145-155.

Quigley, Paul A (2002) Family and community burdens of addiction: case-mix analysis at a new community-based methadone treatment service. Drugs: Education, Prevention and Policy , 9 , (3) , pp. 221-231.

McElrath, Karen (2001) Risk behaviors among injecting drug users in Northern Ireland. Substance Use & Misuse , 36 , (14) , pp. 2137-2157.

Gannon, Maria and Farragher, B and Ahmad, I (1996) Absent without leave: can we predict those who go AWOL? Irish Journal of Psychological Medicine , 13 , (1) , pp. 28-30.

Report

Advisory Council on the Misuse of Drugs. (2023) Nitrous oxide – updated harms assessment. London: Advisory Council on the Misuse of Drugs.

European Monitoring Centre for Drugs and Drug Addiction. Ujváry, István and Evans-Brown, Michael and Gallegos, Ana and Planchuelo, Gregorio and de Morais, Joanna and Christie, Rachel and Jorge, Rita and Sedefov, Roumen (2023) Hexahydrocannabinol (HHC) and related substances. Technical report. Luxembourg: Office for Official Publications of the European Communities.

WHO Expert Committee on Drug Dependence. (2023) WHO Expert Committee on Drug Dependence forty-fifth report. Geneva: World Health Organization.

Center for Forensic Science Research & Education. (2023) New potent synthetic opioid— N-Desethyl Isotonitazene —proliferating among recreational drug supply in USA. Pennsylvania: Center for Forensic Science Research & Education.

Center for Forensic Science Research & Education. (2022) N-Desethyl Isotonitazene. Pennsylvania: Center for Forensic Science Research & Education.

NPS Discovery. (2022) NPS discovery toolkit: N,N-Dimethylpentylone. USA: Center for Forensic Science Research & Education.

RADAR. (2022) A guide to common drug names in Scotland. Edinburgh: Public Health Scotland.

NPS Discovery. (2022) NPS discovery toolkit: N-Pyrrolidino Etonitazene. USA: Center for Forensic Science Research & Education.

McNamara, Sinead and Killeen, Nicki and Stokes, Siobhan and Keenan, Eamonn (2022) Irish syringe analysis pilot project. Dublin: HSE National Social Inclusion Office.

Centre on Drug Policy Evaluation. (2022) What’s contaminating Toronto’s drug supply? insights from samples checked by Toronto’s drug checking service January 1 - December 31, 2021. Toronto: Centre on Drug Policy Evaluation.

Krotulski, Alex J and Shinefeld, Jennifer and DeBord, Joshua and Logan, Barry K (2022) Fentanyl purity, potency, & synthesis: real-time testing of opioid drug products in the United States. USA: Center for Forensic Science Research and Education.

Canadian Centre on Substance Use and Addiction. (2022) CCENDU drug alert: Xylazine. Ottawa: Canadian Centre on Substance Use and Addiction.

Advisory Council on the Misuse of Drugs. (2022) ACMD report – A review of the evidence on the use and harms of 2-benzyl benzimidazole (‘nitazene’) and piperidine benzimidazolone (‘brorphine-like’) opioids. London: Advisory Council on the Misuse of Drugs.

Krotulski, Alex J and Shellman Francis, Vanquilla and Fogarty, Melissa F and Walton, Sara E and Logan, Barry K (2022) N-Propyl Butylone. Pennsylvania: Center for Forensic Science Research & Education.

Angus, Colin and Henney, Madeleine and Pryce, Robert (2022) Modeling the impact of changes in alcohol consumption during the COVID-19 pandemic on future alcohol-related harm in England. Sheffield: University of Sheffield.

Krotulski, Alex J and Shinefeld, Jennifer and Fogarty, Melissa F and DeBord, Joshua and Logan, Barry K (2022) CH-FUBIATA. Pennsylvania: Center for Forensic Science Research & Education.

Krotulski, Alex J and Shellman Francis, Vanquilla and Farrell, Ryan and Roberson, Zachary and Fogarty, Melissa F and Walton, Sara E and Logan, Barry K (2022) N-Cyclohexyl Butylone. Pennsylvania: Center for Forensic Science Research & Education.

European Monitoring Centre for Drugs and Drug Addiction. (2022) New psychoactive substances: 25 years of early warning and response in Europe. An update from the EU Early Warning System. Luxembourg: Publications Office of the European Union.

Canadian Centre on Substance Use and Addiction. (2022) Community urinalysis and self-report project cross-Canada report on the use of drugs from the unregulated supply, 2019-2021 data. Ottawa: Canadian Centre on Substance Use and Addiction.

Krotulski, Alex J and Fogarty, Melissa F and Papsun, Donna M and Lamb, Michael and Walton, Sara E and Logan, Barry K (2022) Synthetic stimulant market rapidly changing as N,N-Dimethylpentylone replaces Eutylone in drug supply typically sold as “ecstasy” or “molly”. Pennsylvania: Center for Forensic Science Research & Education.

Krotulski, Alex J and Farrell, Ryan and Mohaupt, Amanda and Fogarty, Melissa F and Walton, Sara E and Logan, Barry K (2022) CH-PIATA. Pennsylvania: Center for Forensic Science Research & Education.

European Monitoring Centre for Drugs and Drug Addiction. (2022) Report on the risk assessment of 2-(methylamino)-1-(3-methylphenyl)propan-1-one (3-methylmethcathinone, 3-MMC) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended). Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2022) Report on the risk assessment of 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3-chloromethcathinone, 3-CMC) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended). Luxembourg: Publications Office of the European Union.

Krotulski, Alex J and McBride, Amy and Brown, Kyle and Fogarty, Melissa F and Logan, Barry K (2022) Dipyanone. Pennsylvania: Center for Forensic Science Research & Education.

National Health and Medical Research Council. (2022) Inhalation toxicity of non-nicotine e-cigarette constituents: risk assessments, scoping review and evidence map. Canberra: National Health and Medical Research Council.

World Health Organization. (2022) WHO Expert Committee on Drug Dependence: forty-fourth report. Geneva: World Health Organization.

Krotulski, Alex J and Farrell, Ryan and Mohaupt, Amanda and Fogarty, Melissa F and Logan, Barry K (2021) NPS discovery: BZO-CHMOXIZID. Pennsylvania: Center for Forensic Science Research & Education.

European Monitoring Centre for Drugs and Drug Addiction. (2021) Risk assessment report on a new psychoactive substance: methyl 3,3-dimethyl-2-{[1-(pent-4-en-1-yl)-1H-indazole-3-car- bonyl]amino}butanoate (MDMB-4en-PINACA) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended). Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2021) Risk assessment report on a new psychoactive substance: methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3-dime- thylbutanoate (4F-MDMB-BICA) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended). Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

Krotulski, Alex and Papsun, Donna and Mata, Dani and Ellefsen, Kayla and Shoff, Elisa and Shanks, Kevin and Sofalvi, Szabolcs and Kacinko, Sherri and Lewallen, Wayne and Vikingsson, Svante and Logan, Barry (2021) Recommended scope for NPS testing in the United States. Based on trends observed in Q1 2021. Arizona: Society of Forensic Toxicologists.

Ward, Mike and Holmes, Mark (2021) Predicting Risk in Drinkers: Drinking and You (PRIDDY). London: Humankind.

European Monitoring Centre for Drugs and Drug Addiction. (2020) EMCDDA operating guidelines for the risk assessment of new psychoactive substances. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2020) Risk assessment report on the new psychoactive substance N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1- ethanamine (isotonitazene) in accordance with Article 5c of Regulation (EC) No 1920/2006. Luxembourg: Publications Office of the European Union.

Perry, Rachel and Adams, Emma and Harland, Jill and Giles, Emma L and McGeechan, Grant and O'Donnell, Amy and Broadbridge, Angela and Ramsay, Sheena (2020) Understanding high mortality rates among people with multiple and complex needs. Newcastle: Fuse, The Centre for Translational Research in Public Health.

McNeely, Jennifer and Adam, Angéline (2020) Substance use screening and risk assessment in adults. Baltimore, MD: Johns Hopkins University.

Monk, Rebecca L and Heim, Derek and Kuntsche, Emmanuel and Cook, Megan and Labhart, Florian and Qureshi, Adam and Kuntsche, Sandra and Leather, Jessica (2020) Development and first validation of the Refined Alcohol Expectancy Task (RAET). London: Alcohol Change UK.

Peacock, Amy and Farrell, Michael and Muscat, Chelsea and Degenhardt, Louisa (2020) Viability of an Early Warning System (ViEWS) study: final report. Sydney: National Drug and Alcohol Research Centre, UNSW Sydney.

European Monitoring Centre for Drugs and Drug Addiction. (2019) EMCDDA operating guidelines for the European Union Early Warning System on new psychoactive substances. Luxembourg: Publications Office of the European Union.

Alcohol Change UK. (2019) Learning from tragedies: an analysis of alcohol-related Safeguarding Adult reviews published in 2017. London: Alcohol Change UK.

European Monitoring Centre for Drugs and Drug Addiction. (2018) Report on the risk assessment of 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) in the framework of the Council Decision on new psychoactive substances. Risk Assessments. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2018) Report on the risk assessment of N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) in the framework of the Council Decision on new psychoactive substances. Risk Assessments. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2018) Report on the risk assessment of N-(4-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide (4-fluoroisobutyrylfentanyl 4F-iBF), in the framework of the Council Decision on new psychoactive substances. Risk Assessments. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2018) Report on the risk assessment of methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate (5F-MDMB-PINACA; 5F-ADB) in the framework of the Council Decision on new psychoactive substances. Risk Assessments. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2018) Report on the risk assessment of N-phenyl-N-[1-(2-phenylethyl)piperidin-4- yl]oxolane-2-carboxamide (THF-F) in the framework of the Council Decision on new psychoactive substances. Risk assessments. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2018) Report on the risk assessment of N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA) in the framework of the Council Decision on new psychoactive substances. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2018) Report on the risk assessment of 1-(4-Cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (CUMYL-4CN-BINACA) in the framework of the Council Decision on new psychoactive substances. Luxembourg: Publications Office of the European Union.

Ireland. Department of Finance. (2018) Irish gambling sector risk assessment. Dublin: Department of Finance.

European Monitoring Centre for Drugs and Drug Addiction. (2018) Report on the risk assessment of N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA) in the framework of the Council Decision on new psychoactive substances. Risk Assessments. Luxembourg: European Monitoring Centre for Drugs and Drug Addiction.

Health Protection Surveillance Centre. (2018) Guidelines for the emergency management of injuries and Post-exposure Prophylaxis (PEP) (including needlestick and sharps injuries, sexual exposure and human bites) where there is a risk of transmission of bloodborne viruses and other infectious diseases. Dublin: Health Protection Surveillance Centre.

Drug Policy Modelling Program. Barratt, Monica J and Kowalski, Michala and Maier, Larissa and Ritter, Alison (2018) Global review of drug checking services operating in 2017. Sydney: National Drug and Alcohol Research Centre, UNSW Sydney.

European Monitoring Centre for Drugs and Drug Addiction. (2017) Report on the risk assessment of N-(1‑phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl) in the framework of the Council Decision on new psychoactive substances. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2017) Report on the risk assessment of N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide (furanylfentanyl) in the framework of the Council Decision on new psychoactive substances. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2017) Report on the risk assessment of methyl 2-[[1-(cyclohexylmethyl)-1H-indole-3-carbonyl]amino]-3,3-dimethylbutanoate (MDMB-CHMICA) in the framework of the Council Decision on new psychoactive substances. Luxembourg: Publications Office of the European Union.

Higgins, A and Morrissey, J and Doyle, L and Bailey, J and Gill, A (2015) Best practice principles for risk assessment and safety planning for nurses working in mental health services. Dublin: Health Service Executive.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2014) EMCDDA–Europol 2013 annual report on the implementation of Council Decision 2005/387/JHA. Brussels: EMCDDA; Europol.

Europol, European Monitoring Centre for Drugs and Drug Addiction. (2014) EMCDDA–Europol Joint report on a new psychoactive substance: AH-7921. (3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide). Lisbon: European Monitoring Centre for Drugs and Drug Addiction & Europol.

Europol, European Monitoring Centre for Drugs and Drug Addiction. (2014) EMCDDA–Europol joint report on a new psychoactive substance: 25I-NBOMe. (4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine). Lisbon: European Monitoring Centre for Drugs and Drug Addiction & Europol.

Europol, European Monitoring Centre for Drugs and Drug Addiction. (2014) EMCDDA–Europol Joint report on a new psychoactive substance: methoxetamine (2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone). Lisbon: European Monitoring Centre for Drugs and Drug Addiction & Europol.

Europol, European Monitoring Centre for Drugs and Drug Addiction. (2014) EMCDDA–Europol Joint report on a new psychoactive substance: MDPV (3,4-methylenedioxypyrovalerone). Lisbon: European Monitoring Centre for Drugs and Drug Addiction & Europol.

Shannon, Geoffrey and Gibbons, Norah (2012) Report of the Independent Child Death Review Group 2000-2010. Dublin: Government Publications.

European Monitoring Centre for Drugs and Drug Addiction, European Centre for Disease Prevention and Control. (2012) Joint EMCDDA and ECDC rapid risk assessment. HIV in injecting drug users in the EU/EEA, following a reported increase of cases in Greece and Romania. Lisbon: European Monitoring Centre for Drugs and Drug Addiction; European Centre for Disease Prevention and Control.

Walker, Janet and Donaldson, Cam (2011) Intervening to improve outcomes for vulnerable young people: a review of the evidence. London: Department of Education.

European Monitoring Centre for Drugs and Drug Addiction. Sedefov, Roumen and Gallegos, Ana (2011) Report on the risk assessment of mephedrone in the framework of the Council Decision on new psychoactive substances. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2010) Europol–EMCDDA joint report on a new psychoactive substance: 4-methylmethcathinone (mephedrone). Lisbon: European Monitoring Centre for Drugs and Drug Addiction & Europol.

European Monitoring Centre for Drugs and Drug Addiction. (2010) Risk assessment of new psychoactive substances — operating guidelines. Luxembourg: The Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2010) Risk assessment report of a new psychoactive substance: 4-methylmethcathinone (mephedrone). Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction, Inter-American Drug Abuse Control Commission of the Organization of American States. Goosdeel, Alexis (2010) Building a national drugs observatory: a joint handbook. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2009) Report on the risk assessment of BZP in the framework of the Council decision on new psychoactive substances. Luxembourg: Office for Official Publications of the European Communities.

National Treatment Agency for Substance Misuse. (2009) Young people’s specialist substance misuse treatment: needs assessment good practice guidance. London: National Treatment Agency for Substance Misuse.

Advisory Council on the Misuse of Drugs. (2008) GBL & 1,4-BD: Assessment of risk to the individual and communities in the UK. London: Home Office.

European Monitoring Centre for Drugs and Drug Addiction. King, Leslie A and Sedefov, Roumen (2007) Early-warning system on new psychoactive substances: operating guidelines. Luxembourg: Office for Official Publications of the European Communities.

Scottish Executive. Substance Misuse Division. Effective Interventions Unit. (2004) Young people with, or at risk of developing, problematic substance misuse: a guide to assessment. Edinburgh: Stationery Office.

European Monitoring Centre for Drugs and Drug Addiction. (2004) Report on the risk assessment of 2C-I, 2C-T-2 and 2C-T-7 in the framework of the joint action on new synthetic drugs. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2004) Report on the risk assessment of TMA-2 in the framework of the joint action on new synthetic drugs. Luxembourg: Office for Official Publications of the European Communities.

Whittaker, Anne (2003) Substance use in pregnancy. A resource pack for professionals in Lothian. Edinburgh: NHS Lothian.

European Monitoring Centre for Drugs and Drug Addiction. (2002) Report on the risk assessment of GHB in the framework of the joint action on new synthetic drugs. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2002) Report on the risk assessment of ketamine in the framework of the joint action on new synthetic drugs. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2002) Report on the risk assessment of PMMA in the framework of the joint action on new synthetic drugs. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (1999) Report on the risk assessment of MBDB in the framework of the joint action on new synthetic drugs. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (1999) Guidelines for the risk assessment of new synthetic drugs. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (1999) Report on the risk assessment of 4-MTA in the framework of the joint action on new synthetic drugs. Luxembourg: Office for Official Publications of the European Communities.

Webpage

HSE drugs.ie. (2023) Drug trend updates and warnings. URL: https://www.drugs.ie/drugs_info/drug_trend_updates...

WHO Expert Committee on Drug Dependence. (2023) Expert Committee on Drug Dependence information repository. URL: https://ecddrepository.org/en

CREW 2000, University of Stirling. (2023) The Scottish drug checking project. URL: https://www.crew.scot/the-scottish-drug-checking-p...

European Monitoring Centre for Drugs and Drug Addiction. (2022) Infographic: synthetic cathinones notifications to the Early Warning System and seizures. URL: https://www.emcdda.europa.eu/media-library/infogra...

European Monitoring Centre for Drugs and Drug Addiction. (2022) Risk assessment of new psychoactive substances (NPS). URL: https://www.emcdda.europa.eu/publications/topic-ov...

Thesis

Murray, Denis (2013) Professionals’ understanding of risk factors for substance misuse by young people and approaches to intervention. Masters thesis, National University of Ireland, Galway.

Cahill, Paul (2005) Latent variable mixture modelling: an examination of the influences and profiles of treated drug misuse in the Republic of Ireland. PhD thesis, University of Ulster.

Video

European Monitoring Centre for Drugs and Drug Addiction. (2022) EMCDDA webinar: How wastewater monitoring can boost preparedness for new health threats. EMCDDA.

Sutherland, Rachel (2022) NDARC webinar series presentation: Feasibility and consumer acceptability of take-home fentanyl test strips. National Drug and Alcohol Research Centre.

Teaching Resource

Lown, JM (2011) The Financial Self-Efficacy Scale (FSES). Outcomes measurement tool: personal circumstances & needs – debt and finance.

Stein, LAR and Katz, B and Colby, SM and Barnett, NP and Golembeske, C and Lebeau-Craven, R and Monti, Peter M (2006) Alcohol Expectancy Questionnaire-Adolescent, Brief (AEQ-AB). Outcomes measurement tool: attitudes & feelings - attitudes (towards drug and alcohol use).

NHS Health Scotland, University of Warwick and University of Edinburgh. (2006) The Warwick-Edinburgh Mental Well-being Scale (WEMWBS). Outcomes measurement tool: personal circumstances & needs – mental health.

Brown, KW and Ryan, RM (2003) Mindfulness questionnaire. Outcomes measurement tool: attitudes & feelings - thinking differently.

Kroenke, K and Spitzer, R and Williams, W (2001) Patient Health Questionnaire (PHQ9). Outcomes measurement tool: personal circumstances & needs – mental health.

Oberg, D and Sallmen, B and Kaplan, C and McMurphy, S and Ackerson, T and Krantz, L and Martens, P and Schlyter, F and Turner, T (1998) Addiction Severity Index – crime. Outcomes measurement tool: personal circumstances & needs – criminal activity; drug use behaviour - substance use / maintenance / relapse.

Carver, CS (1997) COPE. Outcomes measurement tool: attitudes & feelings - self-determination.

Carver, CS (1997) COPE: positive reframing subscale. Outcomes measurement tool: attitudes & feelings - thinking differently.

Carver, CS (1997) COPE spirituality subscale. Outcomes measurement tool: attitudes & feelings - spirituality.

Simpson, D Dwayne (1997) The Texas Christian University HIV/AIDS Risk Assessment. Outcomes measurement tool: drug use behaviour – safer use.

Martin, Garth W (1991) Drug avoidance self-efficacy scale (DASES). Outcomes measurement tool: attitudes & feelings - self-efficacy.

Torrealday, O and Stein, LAR and Barnett, N and Golembeske, C and Lebeau, R and Colby, SM and Monti, M (1991) Marijuana Effect Expectancy Questionnaire-Brief (MEEQ-B). Outcomes measurement tool: attitudes & feelings - attitudes (towards drug and alcohol use).

Litman, Gloria K and Stapleton, J and Oppenheim, AN and Peleg, M (1983) Coping Behaviours Inventory (CBI). Outcomes measurement tool: drug use behaviour - substance use / maintenance / relapse.

Wiemann, JM (1977) Communicative competence scale. Outcomes measurement tool: employment & skills – communication skills & interpersonal skills.

Brodman, K and Erdmann, AJ and Lorge, I and Wolff, HG (1949) Health Questionnaire. Outcomes measurement tool: personal circumstances & needs – physical health.

Keyson, M and Janda, L Drinking related internal-external locus of control scale. Outcomes measurement tool: attitudes & feelings - attitudes (towards drug and alcohol use). Unpublished.

Beliefs about consequences. Outcomes measurement tool: attitudes & feelings - attitudes (towards drug and alcohol use).

Decision making skills. Outcomes measurement tool: attitudes & feelings - self-determination.

Assertiveness. Outcomes measurement tool: attitudes & feelings - self-determination.

Normative influences. Outcomes measurement tool: relationships – social networks / peer relationships.

News

[Irish Times] , Kelleher, Olivia ‘High-risk’ synthetic opioid being sold in Dublin and Cork as heroin, HSE warns. (13 Jan 2024)

[Health Service Executive] The HSE aims to engage with festivals and nightlife providers over the next year to expand service provision. (18 Aug 2022)

Food Safety Authority of Ireland. Recall of certain batches of CBD and hemp oil products due to the presence of unsafe levels of delta‐9‐tetrahydrocannabinol (THC). (14 Jul 2022)

[Irish Examiner] , English, Eoin HSE defends installation of biohazard bins in Cork. (21 Jan 2019)

[EMCDDA] New legislation published today to bring faster response to new drugs. (21 Nov 2017)

[Independent.ie] , Halpin, Hayley New 'SafeSesh' kits allow college students test quality of recreational drugs. (13 Mar 2017)

[Limerick Post] Special training to tackle Limerick's drug litter. (11 Apr 2014)

This list was generated on Tue Mar 19 04:30:15 2024 GMT.